Physician

Robert Thaddeaus Chapdelaine, MD

According to 2025 Medicare claims, Robert Chapdelaine, MD (NPI: 1710080056) practices pain management in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is PREMIER BRAIN AND SPINE, LLC (NPI: 1922771377; TIN: 871737086) and primary practice location at 08361-8486.

Chapdelaine's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 388 traditional Medicare patients, billed 2,250 HCPCS/CPT codes, and received $188,451 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 5,756 prescription claims across 716 beneficiaries totaling $152,494 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). 2023 DME data shows 16 claims. Open Payments data shows 9 records totaling $371. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $524,986 and ending at $188,451. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $620,330 to $152,494. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	731	7,106	$524,986
2016	723	3,525	$264,300
2017	668	5,305	$381,567
2018	638	5,130	$333,502
2019	525	5,935	$379,806
2020	473	4,707	$371,242
2021	444	3,955	$400,606
2022	465	4,332	$381,089
2023	522	4,268	$405,870
2024	388	2,250	$188,451

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	645	3,360	$620,330
2016	459	1,977	$186,324
2017	639	3,029	$228,330
2018	684	3,487	$157,447
2019	655	3,776	$129,029
2020	497	3,444	$91,325
2021	546	2,967	$92,666
2022	502	2,014	$82,945
2023	706	4,086	$145,428
2024	716	5,756	$152,494

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	126	204	$37,385
2016	31	210	$9,015
2017	N/R	17	$996
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	16	16	$11,020
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	35	44	$199
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	62	62	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	275	616	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	287	954	$71
20610	Aspiration and/or injection of fluid from large joint	37	49	$53

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	163	4,091	$27,283
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	746	19,784	$14,522
Belbuca	Buprenorphine Hcl	22	655	$14,325
Lyrica	Pregabalin	12	360	$9,870
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	636	16,860	$8,241

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$371	Braeburn Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert Thaddeaus Chapdelaine, MD?

Tedicare shows public-source Medicare data for Robert Thaddeaus Chapdelaine, MD (NPI 1710080056), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Thaddeaus Chapdelaine, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Thaddeaus Chapdelaine, MD?

Robert Thaddeaus Chapdelaine, MD is linked to PREMIER BRAIN AND SPINE, LLC (billing NPI 1922771377) in the available physician profile data.

Does Robert Thaddeaus Chapdelaine, MD have Open Payments data?

Robert Thaddeaus Chapdelaine, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.